More Than 30% Upside Seen For Vertex Stock On The Heels Of Phase 2 Data By: Benzinga via Benzinga July 19, 2017 at 09:45 AM EDT Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)'s stock soared 25 percent after the company reported encouraging phase 2 data. ... Read More >> Related Stocks: Vertex Pharmaceuticals